Drug profile · INN
beremagene geperpavec
VYJUVEK
beremagene geperpavec (VYJUVEK) is a collagen alpha-1(vii) chain exogenous gene. Associated with Krystal Biotech Netherlands B.V..
EMA: approved Dermatologicals (D03) D03AX16
Patents linked 2
Pipeline programs 2
News articles 0
Drug details — beremagene geperpavec
- Class
- Dermatologicals (D03)
- Route
- —
- Patents
- 2
- Programs
- 2
- Data quality
- 0.89
Quick answer
beremagene geperpavec (VYJUVEK) is a collagen alpha-1(vii) chain exogenous gene. Associated with Krystal Biotech Netherlands B.V..
Key facts
INN beremagene geperpavec
Brand VYJUVEK
Mechanism Collagen alpha-1(VII) chain exogenous gene
Target Collagen alpha-1(VII) chain
Therapeutic class Dermatologicals (D03)
ATC code D03AX16
Originator Krystal Biotech Netherlands B.V.
Mechanism of action
Collagen alpha-1(VII) chain exogenous gene
Primary target: Collagen alpha-1(VII) chain
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is beremagene geperpavec?
beremagene geperpavec (VYJUVEK) is a collagen alpha-1(vii) chain exogenous gene. Associated with Krystal Biotech Netherlands B.V..
What is the brand name for beremagene geperpavec?
VYJUVEK is a marketed brand name for beremagene geperpavec. Check FDA Drugs@FDA for the current US label holder and prescribing information.